Search Results - "Tardy, S"

Efficacy of anti‐PD1 therapy in relapsed or refractory NK/T cell lymphoma: a matched cohort analysis from the LYSA by Marouf, A., Chaubard, S., Michot, J., Liévin, R., Rossignol, J., Golfier, C., Allangba, O., Philippe, L., Tessoulin, B., Chauchet, A., Deau, B., Oberic, L., Vargaftig, J., Moignet, A., Clavert, A., Dulery, R., Brisou, G., Tardy, S., Fataccioli, V., Houot, R., Casasnovas, R., Thieblemont, C., Ghesquières, H., Carras, S., Le Gouill, S., Cartron, G., Marabelle, A., Tournilhac, O., Damaj, G., Gaulard, P., Leval, L., Lemonnier, F., Bachy, E., Hermine, O., Couronné, L., Jaccard, A.

Get full text

Combination of CD160 and CD200 as a useful tool for differential diagnosis between chronic lymphocytic leukemia and other mature B-cell neoplasms by Lesesve, J.-F., Tardy, S., Frotscher, B., Latger-Cannard, V., Feugier, P., De Carvalho Bittencourt, M.

“…Summary Introduction Chronic lymphocytic leukemia is usually diagnosed through the characteristic morphology/immunophenotype of the lymphocytes, but some CLL…”
Get full text

P1632: PROSPECTIVE OBSERVATIONAL STUDY IN PATIENTS WITH IDIOPATHIC THROMBOCYTOPENIC PURPURA (ITP) TREATED WITH TPO‐R AGONISTS (TPO‐RA): ELTROMBOPAG (EPAG) AND ROMIPLOSTIM (ROMI) ‐ THE PEPITE STUDY by Chèze, S., Quittet, P., Adoue, D., Viallard, J.‐F., Sève, P., Bonnotte, B., Laribi, K., Tardy, S., Henique, H., Hamidou, M., Hacini, M., Santagostino, A., Leclerc‐Teffahi, S., Aroichane, M., Filipovics, A., Brini, F., Velasquez Giron, H., Malatesta, A., Michel, M.

Get full text

Induction of Apoptosis by Wild-Type p53 in a Human Colon Tumor-Derived Cell Line by Shaw, P., Bovey, R., Tardy, S., Sahli, R., Sordat, B., Costa, J.

“…A wild-type p53 gene under control of the metallothionein MT-1 promoter was stably transfected into human colon tumor-derived cell line EB. Repeated inductions…”
Get full text

PD‐1 BLOCKADE IN A FRENCH SERIES OF 13 RELAPSED / REFRACTORY NK/T‐CELL LYMPHOMA PATIENTS by Couronné, L., Chaubard, S., Bruneau, J., Laurent, C., Rossignol, J., Suarez, F., Moignet Autrel, A., Clavert, A., Duléry, R., Alexis, M., Lemonnier, F., Noël, R., Tardy, S., Gaulard, P., Fataccioli, V., Kataoka, K., Ghesquières, H., Salles, G., Bachy, E., Hermine, O., Jaccard, A.

Get full text

G.P.105 by Dorchies, O.M, Ismail, H.M, Tardy, S, Reutenauer-Patte, J, Dahmane, E, Décosterd, L.A, Picard, D, Ruegg, U.T, Scapozza, L

“…We are investigating the effects of selective estrogen receptor modulators (SERMs) in mdx5Cv dystrophic mice (Dys), a model for Duchenne muscular dystrophy…”
Get full text

Regulation of the Actin Cycle in vivo by Actin Filament Severing by McGrath, James L., Osborn, Eric A., Tardy, Yanik S., Dewey, C. Forbes, Hartwig, John H.

“…Cycling of actin subunits between monomeric and filamentous phases is essential for cell crawling behavior. We investigated actin filament turnover rates,…”
Get full text

Solid Phase Synthesis and Restriction Endonuclease Cleavage of Oligodeoxynucleotides Containing 5-(Hydroxymethyl)-Cytosine by Tardy-Planechaud, Séverine, Fujimoto, June, Lin, Susan S., Sowers, Lawrence C.

“…Emerging data suggest an important role for cytosine methylation in tumorigenesis. Simultaneously, recent studies indicate a significant contribution of…”
Get full text

Evaluation of new gingival retraction agents by Bowles, W H, Tardy, S J, Vahadi, A

“…Current gingival retraction agents are not without undesirable side-effects; there appears to be no ideal gingival retraction agent. Several sympathomimetic…”
Get more information

146P A novel allosteric oral immunotherapy small molecule modulates adenosine 2a receptor signaling and restores anti-tumor immune responses by Pejoski, D., Suess, C., Gouiller, A., Héritier, M., Boujut, M., Tardy, S., De Smedt, T., Galibert, L., Reith, W., Joerger, M., Toso, C., Kössler, T., Hamed, H., Scapozza, L.

Get full text

Prognostic implications of expression of the cellular genes myc, fos, Ha-ras and Ki-ras in colon carcinoma by Monnat, M, Tardy, S, Saraga, P, Diggelmann, H, Costa, J

“…Messenger RNA levels of the c-fos, c-myc, c-Ha-ras and c-Ki-ras genes were studied in 39 tissue samples obtained from 17 patients undergoing surgery for colon…”
Get more information

Synthesis and biological evaluation of benzo[4,5]imidazo[1,2-c]pyrimidine and benzo[4,5]imidazo[1,2-a]pyrazine derivatives as anaplastic lymphoma kinase inhibitors by Tardy, Sébastien, Orsato, Alexandre, Mologni, Luca, Bisson, William H., Donadoni, Carla, Gambacorti-Passerini, Carlo, Scapozza, Leonardo, Gueyrard, David, Goekjian, Peter G.

“…Novel fused tricyclic heterocycles were prepared as inhibitors of oncogenic fusion proteins of the ALK tyrosine kinase. The best compound was active against wt…”
Get full text

Combination of CD 160 and CD 200 as a useful tool for differential diagnosis between chronic lymphocytic leukemia and other mature B‐cell neoplasms by Lesesve, J.‐F., Tardy, S., Frotscher, B., Latger‐Cannard, V., Feugier, P., De Carvalho Bittencourt, M.

“…Summary Introduction Chronic lymphocytic leukemia is usually diagnosed through the characteristic morphology/immunophenotype of the lymphocytes, but some CLL…”
Get full text

G.P.105: Preclinical evaluation of tamoxifen and other selective estrogen receptor modulators in mdx5Cv dystrophic mice by Dorchies, O.M., Ismail, H.M., Tardy, S., Reutenauer-Patte, J., Dahmane, E., Décosterd, L.A., Picard, D., Ruegg, U.T., Scapozza, L.

“…We are investigating the effects of selective estrogen receptor modulators (SERMs) in mdx5Cv dystrophic mice (Dys), a model for Duchenne muscular dystrophy…”
Get full text

PF387 FRENCH IBRUTINIB OBSERVATIONAL STUDY (FIRE): REAL‐WORLD STUDY OF IBRUTINIB TREATMENT FOR CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) IN FRANCE by Dartigeas, C., Feugier, P., Ysebaert, L., Dilhuydy, M.‐S., Delmer, A., Tardy, S., Anglaret, B., Voillat, L., DÛ, K., Slama, B., Albrecht, C., Jenayah, L., Beauclair, S., Wapenaar, R., Kavanagh, C., Leblond, V.

“…Background: Ibrutinib is a first‐in‐class oral inhibitor of Bruton's tyrosine kinase approved for the treatment of adult patients (pts) with CLL. Single‐agent…”
Get full text

Étude observationnelle prospective sur les Patients attEints de Purpura Thrombopénique Idiopathique (PTI) traités par des agonisTEs des R-TPO (ARTPO) : Eltrombopag et Romiplostim (Étude PEPITE) by Cheze, S., Quittet, P., Adoue, D., Viallard, J.F., Sève, P., Bonnotte, B., Laribi, K., Tardy, S., Henique, H., Graveleau, J., Hacini, M., Santagostino, A., Aroichane, M., Leclerc-Teffahi, S., Niarra, R., Guillemin, S., Malatesta, A., Michel, M.

“…Depuis 2017, les recommandations françaises proposent une utilisation personnalisée, tenant compte de plusieurs critères, des ARTPO (eltrombopag et…”
Get full text

Étude observationnelle prospective sur les patients atteints de Purpura Thrombopénique Immunologique (PTI) traités par des agonisTEs des R-TPO (ARTPO): Eltrombopag (EPAG) et Romiplostim (ROMI) (Etude PEPITE) by Cheze, S., Quittet, P., Adoue, D., Viallard, J.F., Sève, P., Bonnotte, B., Laribi, K., Tardy, S., Henique, H., Hamidou, M., Hacini, M., Santagostino, A., Leclerc-Teffahi, S., Filipovics, A., Brini, F., Munier, J., Malastesta, A., Michel, M.

“…Initialement, l’indication pour EPAG et ROMI concernait les patients adultes splénectomisés ou contre-indiqués à la splénectomie, présentant un PTI ≥12 mois,…”
Get full text

Myélome multiple et anticorps antithrombine : à propos de trois observations by Revuz, S., Devignes, J., Tardy, S., Serrier, C., Michel, J., Hulin, C.

“…Le myélome multiple (MM) avec hyperprotidémie majeure peut être accompagné de troubles de coagulation. Si le syndrome de Willebrand acquis est classiquement…”
Get full text

Regioselective N-vinylation of cyclic thionocarbamates through a vinyl bis-sulfone methodology by Girniene, Jolanta, Tardy, Sébastien, Tatibouët, Arnaud, Sačkus, Algirdas, Rollin, Patrick

“…■■■ A vinyl bis-sulfone Michael type approach towards heteroatom vinylation was applied on nitrogen derivatives. Cyclic thionocarbamates––mainly…”
Get full text

Nouvelle observation de l’efficacité spectaculaire de l’anakinra dans un syndrome de Schnitzler réfractaire by de Korwin, J.-D., Tardy, S., Le Guillou, A.

Get full text